In addition to Richard Zaremba, one other MSON executive reported Sell trades in the last month.
Based on Misonix`s latest earnings report from June 30, the company posted quarterly revenue of $6.75M and quarterly net profit of $3.83M. In comparison, last year the company earned revenue of $5.58M and had a net profit of $1.39M. The company has a one year high of $14.90 and a one year low of $6.51. MSON’s market cap is $84.33M and the company has a P/E ratio of 15.8%.
Looking at blogger coverage of MSON, there is a 100% Bullish tendency on the stock, in relation to a 65% average bullish tendency within the Healthcare sector.
In the last 30 days, insiders have sold $17.3k worth of MSON shares and purchased $967 worth of MSON shares. Over the last 3 months, the insider sentiment on Misonix has been neutral based on 37 corporate insider transactions. This sentiment is higher than the average sector sentiment of insiders.
Misonix Inc designs, manufactures, markets and develops minimally invasive ultrasonic surgical device products. Its products include the BoneScalpel surgical system, the SonaStar Surgical Aspirator and the SonicOne Wound Cleansing and Debridement System.